Vaccine Acceptance and Its Influencing Factors: An Online Cross-Sectional Study among International College Students Studying in China.
China
cross-sectional study
health behavior theory
vaccine acceptance
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
02 Jun 2021
02 Jun 2021
Historique:
received:
15
04
2021
revised:
20
05
2021
accepted:
22
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
With the continuous large-scale development of the COVID-19 vaccine, the acceptance of vaccination and its influencing factors at the individual level have become crucial to stemming the pandemic. This study aims to explore the factors that influence the acceptance of the COVID-19 vaccine among international college students. The target population constituted international students pursuing various degrees in Jiangsu Province through an online cross-sectional study. A cluster random sampling was performed using a self-administered questionnaire. The Health Belief Model and Knowledge, Attitude/Beliefs, and Practice Theory served as the underlying theories to understanding the factors that influence vaccine acceptance. We received 330 responses. About 36.4% intended to accept the vaccine. The acceptance varied across respondents' place of residence, program of study, continent of origin, knowledge, susceptibility, severity, benefits, and cues to action ( The acceptance of the COVID-19 vaccine was low among international students. The correct and comprehensive beliefs of the target groups regarding the benefits and barriers of the vaccination must be raised. Various effective social strategies must be adopted to trigger the intention of COVID-19 vaccination. The study findings will inform the decisions of public health campaigners, aimed at reducing vaccine hesitation when the COVID-19 vaccine is widely available.
Sections du résumé
BACKGROUND
BACKGROUND
With the continuous large-scale development of the COVID-19 vaccine, the acceptance of vaccination and its influencing factors at the individual level have become crucial to stemming the pandemic. This study aims to explore the factors that influence the acceptance of the COVID-19 vaccine among international college students.
METHODS
METHODS
The target population constituted international students pursuing various degrees in Jiangsu Province through an online cross-sectional study. A cluster random sampling was performed using a self-administered questionnaire. The Health Belief Model and Knowledge, Attitude/Beliefs, and Practice Theory served as the underlying theories to understanding the factors that influence vaccine acceptance.
RESULTS
RESULTS
We received 330 responses. About 36.4% intended to accept the vaccine. The acceptance varied across respondents' place of residence, program of study, continent of origin, knowledge, susceptibility, severity, benefits, and cues to action (
CONCLUSIONS
CONCLUSIONS
The acceptance of the COVID-19 vaccine was low among international students. The correct and comprehensive beliefs of the target groups regarding the benefits and barriers of the vaccination must be raised. Various effective social strategies must be adopted to trigger the intention of COVID-19 vaccination. The study findings will inform the decisions of public health campaigners, aimed at reducing vaccine hesitation when the COVID-19 vaccine is widely available.
Identifiants
pubmed: 34199331
pii: vaccines9060585
doi: 10.3390/vaccines9060585
pmc: PMC8228371
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Natural Science Foundation of China
ID : 72074122
Organisme : Philosophy and Social Science Research of Jiangsu Higher Education Institutions of China
ID : 2020SJA0306
Références
Clin Infect Dis. 2011 Apr 1;52(7):911-6
pubmed: 21427399
Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214
pubmed: 32730103
Lancet. 2020 Jun 6;395(10239):1751-1752
pubmed: 32505245
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Front Public Health. 2021 Feb 10;9:632914
pubmed: 33643995
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
Emerg Infect Dis. 2020 Jul;26(7):1575-1579
pubmed: 32298227
J Public Health (Oxf). 2020 Dec 26;:
pubmed: 33367857
Eur J Epidemiol. 2020 Aug;35(8):781-783
pubmed: 32761440
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Vaccine. 2011 Nov 28;29(51):9459-66
pubmed: 22024174
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Nurs Outlook. 2021 Feb 5;:
pubmed: 33610324
Vaccine. 2021 Apr 8;39(15):2060-2067
pubmed: 33741191
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Br J Health Psychol. 2021 May;26(2):679-696
pubmed: 33763971
PLoS One. 2017 Mar 1;12(3):e0172310
pubmed: 28249006
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Vaccine. 2021 Feb 12;39(7):1148-1156
pubmed: 33461834
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Public Health (Oxf). 2021 Mar 03;:
pubmed: 33677601
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713